Shareholders approve Lipocine stock plan amendment; authorized shares raised to 1M

Lipocine Inc.

Shareholders approved Sixth Amended and Restated 2014 Stock Plan on June 3, 2026.
Plan increases individual award limit from 25,000 to 100,000 shares.
Authorized shares increased by 400,000, from 600,000 to 1,000,000 shares.
Four directors elected to one-year terms: Dr. Mahesh V. Patel, John W. Higuchi, Dr. Jill M. Jene, Dr. Richard Dana Ono.
Ratification of Tanner LLC as independent auditor for FY 2026 and advisory vote on executive compensation both approved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.